Real-time enrollment status for this al amyloidosis clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 3:40 PM UTC
| NCT Number | NCT06158854 |
| Recruiting Status | Recruiting |
| Condition | AL Amyloidosis |
| Phase | PHASE1 |
| Target Enrollment | 76 participants |
| Active Locations | 12 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | May 13, 2026 (May 13, 2026) |
As of July 19, 2026: Clinical trial NCT06158854 is currently recruiting participants. This phase1 study for al amyloidosis is actively seeking new participants at 12 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06158854 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06158854 was last updated May 13, 2026 (May 13, 2026). HelloStudys verifies this status automatically.